• Moleculin Biotech will implement a 1-for-20 reverse stock split effective at 12:01 a.m. Eastern Time on October 20, 2026.
• Shares will begin split-adjusted trading on the Nasdaq Capital Market on October 20 under the existing ticker MBRX.
• Outstanding common shares will fall from approximately 20,900,000 to 1,050,000; authorized common shares will remain at 500,000,000.
• Fractional shares will be paid in cash.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Moleculin Biotech Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610160920PRIMZONEFULLFEED9846968) on October 16, 2026, and is solely responsible for the information contained therein.